80 results

• Venclexta Side Effects May Increase Risk Of Death In Multiple Myeloma Patients: FDA

  March 25, 2019

  Martha Garcia

  The FDA warns that clinical trials indicate Venclexta can increase the risk of death when given off-label to patients for the treatment of multiple myeloma.

• Roche To Replace All Warfarin CoaguChek Test Strips In The U.S.

  November 20, 2018

  Russell Maas

  Roche is telling consumers it will replace all recalled CoaguChek Test Strips used in the U.S. to check the effectiveness of warfarin and other blood thinners following a massive recall.

• JAMA Researcher Failed to Disclose Millions In Industry Payments, Sparking Conflict Of Interest Debate

  November 6, 2018

  Irvin Jackson

  A leading cancer researcher who failed to reveal deep industry ties and millions in payments has been ousted from a leading cancer center and sparked debate about the need for full financial disclosures in scientific research.

• CoaguChek Warfarin Test Strips Recalled Over Inaccurate Test Results

  November 6, 2018

  Russell Maas

  More than 1 million CoaguChek test strips used to check blood coagulation have been recalled due to inaccurate results, which can cause medication errors.

• Clinical Trial for Tecentriq-Cotellic Combo Halted After Patient Deaths

  April 13, 2018

  Irvin Jackson

  Roche has temporarily halted a clinical trial of a combination of the cancer drugs Tecentriq and Cotellic following the deaths of several patients involved in the study.

• Actemra Unfit For Use Against Giant Cell Arthritis, UK Regulators Rule

  December 11, 2017

  Irvin Jackson

  U.K. regulators say Actemra is unfit for use in the treatment of giant cell arthritis because it is too expensive.

• Actemra Approval Expanded Amid Increasing Safety Concerns

  September 5, 2017

  Irvin Jackson

  The FDA has expanded the use of Actemra for the treatment of side effects of CAR-T cell therapy amid growing concerns over the drug's potential side effects.

• Actemra Study Looking At Use As Treatment for Systemic Sclerosis

  August 9, 2017

  Irvin Jackson

  Actemra is being tested in an ongoing clinical trial as a potential treatment for systemic sclerosis, despite growing concerns linking the drug to heart attacks, strokes, and deaths.

• Accutane Crohn’s Disease Lawsuits Resurrected By Appeals Court Decision

  August 2, 2017

  Irvin Jackson

  Thousands of Accutane lawsuits have been reinstated after an appeals court determined that a New Jersey judge wrongly dismissed testimony by plaintiffs' expert witnesses.

• Side Effects of Actemra Injection Affected 15% Of Subjects in Giant Cell Arthritis Clinical Trial: Study

  July 28, 2017

  Irvin Jackson

  A new study looking at the use of Actemra to treat giant cell arthritis indicates that 15% of patients could suffer severe side effects.